title: Prolonged hypogonadism after pulsed gonadotropin-releasing hormone agonist for prostate cancer.
authors.forename: M J
authors.initials: MJ
authors.lastname: Stevens
authors.forename: D R
authors.initials: DR
authors.lastname: Bell
authors.forename: S A
authors.initials: SA
authors.lastname: Blome
authors.forename: S D
authors.initials: SD
authors.lastname: Begbie
mesh_terms: D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000139:chemically induced; D005485:Flutamide / Q000008:administration & dosage; D005640:Follicle Stimulating Hormone / Q000097:blood; D017273:Goserelin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D013737:Testis / Q000187:drug effects*; D013739:Testosterone / Q000097:blood
chemical_list: D017273:Goserelin; D013739:Testosterone; D005485:Flutamide; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone